SOPHiA GENETICS (SOPH) Cash from Investing Activities (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Cash from Investing Activities data on file, last reported at -$3.5 million in Q4 2025.

• For the quarter ending Q4 2025, Cash from Investing Activities fell 178.02% year-over-year to -$3.5 million; the trailing twelve-month figure through Dec 2025 stood at -$8.7 million (down 82.33% YoY), and the FY2025 full-year result was -$8.7 million, down 82.33% from the prior year.
• Cash from Investing Activities fell to -$3.5 million in Q4 2025, from -$2.6 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $18.0 million in Q2 2022 to a low of -$52.7 million in Q3 2021.
• A 5-year average of -$770550.0 and a median of -$1.2 million in 2024 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities slumped 7238.58% in 2021 and jumped 1044.1% in 2022, its largest moves.
• Tracing SOPH's Cash from Investing Activities over 5 years: stood at -$1.3 million in 2021, then surged by 1043.12% to $12.1 million in 2022, then tumbled by 80.18% to $2.4 million in 2023, then sank by 152.37% to -$1.3 million in 2024, then slumped by 178.02% to -$3.5 million in 2025.
• Business Quant data shows SOPH's Cash from Investing Activities at -$3.5 million in Q4 2025, -$2.6 million in Q3 2025, and -$1.6 million in Q2 2025.